GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » Net Income From Continuing Operations

Zahravi Pharmacutical Co (XTEH:DZAH1) Net Income From Continuing Operations : IRR0.00 Mil (TTM As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Zahravi Pharmacutical Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Zahravi Pharmacutical Co's net income from continuing operations for the six months ended in . 20 was IRR0.00 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in . 20 was IRR0.00 Mil.


Zahravi Pharmacutical Co Net Income From Continuing Operations Historical Data

The historical data trend for Zahravi Pharmacutical Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zahravi Pharmacutical Co Net Income From Continuing Operations Chart

Zahravi Pharmacutical Co Annual Data
Trend
Net Income From Continuing Operations

Zahravi Pharmacutical Co Semi-Annual Data
Net Income From Continuing Operations

Zahravi Pharmacutical Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in . 20 was IRR0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zahravi Pharmacutical Co (XTEH:DZAH1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18th km of Karaj Special Road, Darupakhsh Street, Darupakhsh Factories, Entrance No. 2, No. 23, Tehran, IRN
Zahravi Pharmacutical Co is engaged in the pharmaceutical sector. It produces various tablets, capsules, injections, and soft gel capsules. Some of its products are Cograft, Iminoral, Clexaparin, Roaccutane, and others.

Zahravi Pharmacutical Co (XTEH:DZAH1) Headlines

No Headlines